| 07 Jan, 09:04 am | — | … | Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release - Wockhardt Files Marketing Authorisation Application for WCK 5222 with European Medicines Agency. | nse |
| 01 Jan, 05:44 pm | — | … | Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, we wish to inform you that ESG Risk Assessments & Insights Limited, a SEBI-registered ESG rating provider, has voluntarily assigned an ESG rating of 73 (Excellent) for the year 2025 as part of its ESG assessment process. | nse |
| 31 Dec, 06:22 pm | — | … | Wockhardt Limited has informed the Exchange that SES ESG Research Pvt Ltd, a SEBI registered ESG rating provider, has voluntarily assigned an ESG rating of 67.3 for the Financial Year 2024-25 | nse |
| 31 Dec, 04:31 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | bse |
| 31 Dec, 04:25 pm | — | … | In terms of provisions of Regulation 30 (read with Part A of Schedule III) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ( Listing Regulations ), we wish to inform you that the Company is in receipt of the Tax Demand Order dated 26th December, 2025 passed by the Superintendent, Central GST Range-11, Division-III, Ghaziabad for the period FY 2019-20 amounting to Rs. 90,23,518/- (Ninety Lakh Twenty Three Thousand Five Hundred and E | nse |
| 31 Dec, 12:34 pm | — | … | Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release European Medicines Agency Grants Accelerated Assessment to WCK 5222 ". | nse |
| 31 Dec, 12:26 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 16 Dec, 04:42 pm | — | … | Wockhardt Ltd - 532300 - Intimation For Incorporation Of Step-Down Subsidiaries Of The Company. | bse |
| 16 Dec, 04:35 pm | — | … | Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that Wockhardt Bio AG, a subsidiary of the Company, has incorporated three new Wholly Owned Subsidiaries Wockhardt Swiss AG (Switzerland), Wockhardt Suisse USA Holding Corporation (USA) and Wockhardt Suisse USA LLC (USA). Consequent to the incorporation, Wockhardt Swiss AG, Wockhardt Suisse USA Holding Corporation | nse |
| 02 Dec, 01:15 pm | — | … | Wockhardt Ltd - 532300 - Reply To Email Related To Volume Movement | bse |
| 02 Dec, 11:57 am | — | … | Wockhardt Ltd - 532300 - Clarification sought from Wockhardt Ltd | bse |
| 01 Dec, 11:39 am | — | … | Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release US FDA Accepts Wockhardt s New Drug Application for Breakthrough Antibiotic Zaynich . | nse |
| 01 Dec, 11:38 am | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 04 Nov, 01:09 pm | — | … | Wockhardt Ltd - 532300 - Reply To Your Email Dated 4Th November, 2025 Relating To Volume Movement | bse |
| 04 Nov, 11:18 am | — | … | Wockhardt Ltd - 532300 - Clarification sought from Wockhardt Ltd | bse |
| 03 Nov, 06:27 pm | — | … | Pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 173A of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed Monitoring Agency Report towards utilization of proceeds of Qualified Institutions Placement ( QIP ) for the quarter ended September 30, 2025, issued by CRISIL Ratings Limited, duly reviewed and taken on record by the Board of Directors & Audit Committee of the Com | nse |
| 03 Nov, 06:17 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | bse |
| 03 Nov, 03:35 pm | — | … | Wockhardt Limited has informed the Exchange regarding a press release dated November 03, 2025, titled "Submission pursuant to Regulation 30 of SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015 ( Listing Regulations ) - Press Release". | nse |
| 03 Nov, 03:31 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 03 Nov, 03:20 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 03 Nov, 03:08 pm | — | … | Wockhardt Ltd - 532300 - Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025 | bse |
| 03 Nov, 02:58 pm | — | … | Wockhardt Limited has informed the Exchange regarding Appointment of Mr. Om Prakash Bhatt as Non- Executive Independent Director of the company w.e.f. November 03, 2025. | nse |
| 03 Nov, 02:55 pm | — | … | Wockhardt Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. | nse |
| 03 Nov, 02:49 pm | — | … | Wockhardt Ltd - 532300 - Board Meeting Outcome for Outcome Of The Board Meeting | bse |
| 29 Oct, 10:33 am | — | … | Wockhardt Ltd - 532300 - Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited ('' The Company''). | bse |
| 01 Oct, 09:02 am | — | … | Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release Wockhardt Submits New Drug Application to U.S. FDA for Zidebactam-Cefepime (WCK 5222) for Treatment of Serious Gram-Negative Infections . | nse |
| 01 Oct, 09:00 am | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 25 Sept, 04:16 pm | — | … | Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release Prestigious Medical and Public Health Journal THE LANCET Regional Health Publishes Pivotal Phase 3 Clinical Study on Miqnaf® (Nafithromycin) A Landmark for India s Antibiotic Innovation . | nse |
| 25 Sept, 04:14 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 12 Sept, 06:16 pm | — | … | Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, we wish to inform you that ESG Risk Assessments & Insights Limited, a SEBI-registered ESG rating provider, has voluntarily assigned an ESG rating of 68 (Strong) for the Financial Year 2024-25 as part of its annual ESG assessment process. | nse |